Literature DB >> 2448888

Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI).

J Gram1, C Kluft, J Jespersen.   

Abstract

We determined during the acute stage of myocardial infarction selected fibrinolysis variables (tissue-type plasminogen activator, intrinsic plasminogen activators, tissue-type plasminogen activator inhibition, C1-inactivator) and related the observed changes to changes in two acute phase reactants (C-reactive protein, fibrinogen). Acute myocardial injury induce significant increases in blood of tissue-type plasminogen activator inhibition (day one, p less than 0.05), C-reactive protein (day three, p less than 0.01), fibrinogen (day six, p less than 0.01), and C1-inactivator (day eight, p less than 0.01). Tissue-type plasminogen activator activity measured as C1-inactivator resistant fibrinolytic activity showed a minimum day two after the acute attack (p less than 0.01), whereas plasminogen activator activities arising from the intrinsic system of fibrinolysis remained constant. The observed changes did not parallel the occurrence of deep vein thrombosis indicated by a positive Tc-plasmin test (41% of the patients).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448888

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Three-dimensional structure of fibrolase, the fibrinolytic enzyme from southern copperhead venom, modeled from the X-ray structure of adamalysin II and atrolysin C.

Authors:  M B Bolger; S Swenson; F S Markland
Journal:  AAPS PharmSci       Date:  2001

2.  Increased tissue-plasminogen activator (t-PA) levels in patients under oral anticoagulant therapy.

Authors:  J Grulich-Henn; K Loechelt; W Speiser; G Müller-Berghaus
Journal:  Blut       Date:  1989-01

3.  Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction.

Authors:  M Tubaro; G Mattioli; F Matta; C Cappello; E Natale; R Ricci; P Gerardi; F Milazzotto
Journal:  Cardiovasc Drugs Ther       Date:  1993-11       Impact factor: 3.727

4.  The role of C-reactive protein on the long-term clinical outcome after primary or rescue percutaneous coronary intervention.

Authors:  Young Joon Hong; Myung Ho Jeong; Ok Young Park; Weon Kim; Ju Han Kim; Young Keun Ahn; Jeong Gwan Cho; Byoung Hee Ahn; Soon Pal Suh; Jong Chun Park; Sang Hyung Kim; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2003-03       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.